The severity and distribution of tau pathology are more strongly correlated with brain atrophy and the clinical presentation of AD than Aβ deposition, though Aβ pathology may have synergistic effects with tau-derived neuronal damage [5,32,36,37]. The gene discussed is MAPT; the disease is Alzheimer disease.